Published Oct 7, 2026
Updated Oct 7, 2026
Physician. Entrepreneur. Inventor. Co-founder of Intuitive Surgical. And, arguably, one of the people who has had the greatest influence on the development of modern surgical robotics.
Frederic H. Moll, MD, has spent more than four decades at the intersection of surgery, medical devices and technology. His career is unusual even within the world of medical innovation: before helping to create one of the most influential companies in modern surgery, he had already founded medical-device companies, developed surgical instruments and acquired a second education in business. But the common thread throughout his career has been remarkably consistent: identify what makes surgery unnecessarily invasive, and find a technological way to change it.
Moll studied economics at the University of California, Berkeley, obtained his MD from the University of Washington, and later completed an MS in Management at Stanford. During his surgical training at Virginia Mason Medical Center in Seattle, he became interested in the problem of gaining access to the body without creating large incisions. That interest led to the development of a safety trocar and, in 1984, to the creation of Endotherapeutics to commercialize it. The company was subsequently acquired by United States Surgical.
He then co-founded Origin Medsystems in 1989, a company focused on laparoscopic surgical technology. Origin was acquired by Eli Lilly in 1992 and subsequently became part of Guidant’s surgical business, where Moll served as medical director. These early ventures were important not only commercially but intellectually: Moll was learning how surgeons, engineers, investors and companies could work together to turn a surgical idea into a clinical technology.
The Intuitive moment
In 1995, Moll co-founded Intuitive Surgical with John Freund and Robert Younge. He became its first CEO. The company was created around a fundamentally different proposition: computer technology could separate the surgeon’s hands from the instruments inside the patient and, in doing so, potentially overcome some of the limitations of conventional minimally invasive surgery.
The result was the da Vinci Surgical System.
Intuitive was founded in 1995 and introduced the first da Vinci system in 2000. The platform combined three-dimensional visualization, a surgeon-controlled interface, computer-mediated instrument motion and wristed instruments. Rather than attempting to make a robot operate independently, the system was designed to make the surgeon’s own movements more capable inside the body.
That distinction is fundamental. The original vision of robotic surgery was not necessarily about replacing the surgeon with a robot. It was about using a computer-controlled mechanical interface to overcome the physical limitations of minimally invasive surgery.
Moll left the operational leadership of Intuitive in the early 2000s, but by then the essential idea had taken hold. The company went on to build what has become the dominant commercial platform in robotic-assisted surgery for the las quarter of a century.
But Intuitive was not the end
Perhaps the most revealing part of Moll’s career is what happened next.
After Intuitive, he did not simply retire from robotic surgery. He founded Hansen Medical, developing robotic technology for catheter-based vascular and electrophysiology procedures. He subsequently became involved in Auris Surgical Robotics, later Auris Health, pursuing a different vision of surgical robotics: smaller, more flexible systems capable of reaching areas of the body through natural or minimally invasive access routes.
Auris developed the Monarch platform for robotic-assisted bronchoscopy. In 2019, Johnson & Johnson acquired Auris Health, and Moll subsequently became Chief Development Officer of J&J’s Medical Devices business. He remained there until 2023. Ottava got FDA approval in 2024.
Another chapter in Fred Moll’s story is his involvement with SS Innovations, the Indian company behind the SSi Mantra surgical robotic system. Moll is now Vice Chairman of the company, bringing his experience from Intuitive Surgical to a very different proposition: developing a robotic platform designed to make robotic surgery more affordable and accessible, particularly in markets where the cost of established systems remains a major barrier. He has also invested in the company alongside founder and cardiac surgeon Sudhir Srivastava. In many ways, it is an interesting full circle: the co-founder of the company that helped establish modern robotic surgery is now involved in a new generation of systems challenging some of the economic assumptions of that first generation.
There are many people who contributed to the development of surgical robotics. Moll is different because his influence has operated at several levels simultaneously.
He was a surgeon, giving him first-hand understanding of the limitations of conventional surgery. He was an inventor and medical-device developer, translating surgical problems into engineering requirements. He was an entrepreneur, repeatedly creating companies capable of bringing those technologies to patients. And, perhaps most importantly, he understood that technological innovation in surgery requires much more than a clever mechanism: it requires clinical adoption, engineering, regulation, investment, training and an ecosystem capable of supporting the technology.
His most important contribution may therefore not be a particular instrument or robot. It may be the idea that surgery itself could become a field of technological innovation. That idea has now become mainstream.
PS. I first heard the name of Fred Moll in my conversations with Akhil Madhani in 2015, when we were discussing the early history of robotic surgery. In one of his emails, Akhil recalled that when he first met Intuitive Surgical, the company was still only about twelve people, and that he had shown Fred Moll, then medical director and co-founder of Intuitive, his “Silver Falcon” system, featuring a cable-driven wrist. Akhil believed that this work provided part of the inspiration for the wrist that would become such a defining feature of the da Vinci system. Since that conversation, I have repeatedly encountered Fred Moll‘s name in the history and evolution of surgical robotics.